Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Aubry

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2017
From Expert Protocols to Standardized Management of Infectious DiseasesJean-Christophe Lagier, Camille Aubry, Marion Delord, et al.
Current Opinion in Microbiology|July 16, 2013
Engineering lactococci and lactobacilli for human healthLuis G Bermúdez-Humarán, Camille Aubry, Jean-Paul Motta, et al.
The Journal of Infectious Diseases|August 17, 2011
OatA, a peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulenceCamille Aubry, Céline Goulard, Marie-Anne Nahori, et al.
Microbial Cell Factories|November 8, 2015
Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse modelCamille Aubry, Christophe Michon, Florian Chain, et al.
Microbial Cell Factories|April 19, 2015
Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococciLuis G Bermúdez-Humarán, Jean-Paul Motta, Camille Aubry, et al.
Plos One|March 21, 2012
Both TLR2 and TRIF contribute to interferon-β production during Listeria infectionCamille Aubry, Sinéad C Corr, Sebastian Wienerroither, et al.
FEMS Microbiology Letters|April 23, 2013
Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an updateJean Guy LeBlanc, Camille Aubry, Naima G Cortes-Perez, et al.
The EMBO Journal|June 21, 2011
Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cellsAna Reynders, Nadia Yessaad, Thien-Phong Vu Manh, et al.
Travel Medicine and Infectious Disease|March 18, 2020
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?Jean Christophe Lagier, Philippe Colson, Hervé Tissot Dupont, et al.
The ISME Journal|July 29, 2015
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic miceThomas W Hoffmann, Hang-Phuong Pham, Chantal Bridonneau, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2017
From Expert Protocols to Standardized Management of Infectious DiseasesJean-Christophe Lagier, Camille Aubry, Marion Delord, et al.
Current Opinion in Microbiology|July 16, 2013
Engineering lactococci and lactobacilli for human healthLuis G Bermúdez-Humarán, Camille Aubry, Jean-Paul Motta, et al.
The Journal of Infectious Diseases|August 17, 2011
OatA, a peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulenceCamille Aubry, Céline Goulard, Marie-Anne Nahori, et al.
Microbial Cell Factories|November 8, 2015
Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse modelCamille Aubry, Christophe Michon, Florian Chain, et al.
Microbial Cell Factories|April 19, 2015
Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococciLuis G Bermúdez-Humarán, Jean-Paul Motta, Camille Aubry, et al.
Plos One|March 21, 2012
Both TLR2 and TRIF contribute to interferon-β production during Listeria infectionCamille Aubry, Sinéad C Corr, Sebastian Wienerroither, et al.
FEMS Microbiology Letters|April 23, 2013
Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an updateJean Guy LeBlanc, Camille Aubry, Naima G Cortes-Perez, et al.
The EMBO Journal|June 21, 2011
Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cellsAna Reynders, Nadia Yessaad, Thien-Phong Vu Manh, et al.
Travel Medicine and Infectious Disease|March 18, 2020
Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?Jean Christophe Lagier, Philippe Colson, Hervé Tissot Dupont, et al.
The ISME Journal|July 29, 2015
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic miceThomas W Hoffmann, Hang-Phuong Pham, Chantal Bridonneau, et al.
Pageof 3